Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
about
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohortsMolecular basis of ligand recognition and transport by glucose transportersGlucose deprivation contributes to the development of KRAS pathway mutations in tumor cellsCurrent perspectives between metabolic syndrome and cancerPathophysiological mechanisms of death resistance in colorectal carcinomaSLC transporters as therapeutic targets: emerging opportunitiesCrystal structure of a glucose/H+ symporter and its mechanism of action.Ligand-based targeted therapy: a novel strategy for hepatocellular carcinomaEnzymatic methods for glyco(diversification/randomization) of drugs and small moleculesMechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amidesMultiscale models of angiogenesisSynthesis and Spectroscopic Evaluation of Two Novel Glycosylated Zinc(II)-Phthalocyanines.Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cellsSystems biology approach to identification of biomarkers for metastatic progression in cancer.Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial.Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancerPyruvate dehydrogenase kinase as a potential therapeutic target for malignant gliomas.Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinomaLC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceIncreased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype.Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cellsThe immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case reportLong-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.Characterization of monocarboxylate transporter activity in hepatocellular carcinomaUpdate information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling.Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.Metabolic profiling and flux analysis of MEL-2 human embryonic stem cells during exponential growth at physiological and atmospheric oxygen concentrationsDifferential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.Serum glucose and risk of cancer: a meta-analysis.Hypoxia regulates the expression of the neuromedin B receptor through a mechanism dependent on hypoxia-inducible factor-1αIntratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis.Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.Synthesis and photophysics of an octathioglycosylated zinc(II) phthalocyanine.Hypoxia remodels the composition of the constituent ceramide species of HexCer and Hex2Cer with phytosphingosine and hydroxy fatty acids in human colon cancer LS174T cells.The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.
P2860
Q21090132-3D1DDFFC-608E-44FE-A57C-63CE99E1AFE2Q24338453-A7E17A01-E77B-46E6-84AC-73EED9256BE3Q24648994-3E6C268E-44B5-4730-8E79-D6E75E83FBCAQ26749299-1151ED67-6CA6-4E88-B2D9-04A03C133470Q26778007-FAEA89A3-831B-44E6-92C4-8B6BDE28EA80Q27014726-BCE29272-6A7F-4D56-A35E-719E9F3853B3Q27680370-2143645A-26F6-49A6-83FF-E5BC951B70A5Q28068437-22CFCB2E-BDE0-4847-97A8-2DB380B0EF50Q28247479-27CB7018-6B50-499D-A858-99A30D6506A9Q28833619-2E03568F-FE87-4335-83A4-6EA1D6CF2C7CQ30432668-1DAF1E08-71CE-4C0D-99E8-896CCA72089CQ31006687-CA2EFC2E-84A3-4534-AE55-0BD88FC0A33FQ31079659-5F1B4572-C74B-4532-BCE1-F222A22BC580Q33369631-7A6C65FB-8282-41A1-B3C0-DA41380D1559Q33394729-E79F6C01-A4AF-469F-8900-EFC86926324BQ33396559-B2125A08-0073-4933-B383-D74B3E47339EQ33635374-277F4F7A-114E-4049-BA22-F5DACFADF29DQ33681427-63279BB4-536C-40EB-9FC7-BF340431FC60Q33733638-D16E6231-D01C-40BD-BAC8-36FF056E4198Q33779972-18E1982B-14FA-4A90-B6D0-648F0F5C5DB6Q33816450-546CB606-44C0-4710-B08C-BB3AB6F486B1Q33818999-BB865723-73AB-4CF7-927B-3AE522B00F13Q33842748-B55F7572-0F01-4371-99DD-E9507FCA6A03Q33934809-01335A43-2825-4FCA-BA04-815CBB03B6EAQ33983602-5DF9D17B-0CEB-43BB-B607-F6C1E43EEEE5Q34105361-22CB1379-8095-412E-8697-255371B3D7F0Q34137358-9DA5BA9D-D04A-484B-8CB2-14011F710715Q34204238-91BA87B6-20AF-4D75-9A71-F9165C9C159CQ34238619-4A7E9982-31BD-4968-A5FB-DAE2723471DDQ34332053-2B1AA84A-4084-4ADB-8137-28C8CC994C1AQ34549776-8D89C5DD-0CEF-454A-BF09-7B6B0D414C66Q34972287-70EAD677-21B8-4FE1-81D9-48084B3798C5Q35059999-B2758A98-372F-4C69-811A-5ED5582FE39AQ35070598-F7287778-D8A2-4A78-8978-BC3B45826503Q35119851-31D52EF9-3B4D-4157-9BC1-0296D81F7DF1Q35188024-0D6A722F-ABC7-4D3D-A7AD-90DFA7C2599FQ35217663-92CFEE06-7D68-49B7-919B-5E94BB3BC1D6Q35237683-5491FBC6-68D8-4D7D-BBF8-A8543B9FD203Q35700822-D50914A8-CC45-4183-A553-F531B8B543AEQ35753643-CFFAA842-D70A-4C4A-85C9-A75A979F0F49
P2860
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hypoxic regulation of glucose ...... s for anticancer therapeutics.
@en
type
label
Hypoxic regulation of glucose ...... s for anticancer therapeutics.
@en
prefLabel
Hypoxic regulation of glucose ...... s for anticancer therapeutics.
@en
P2860
P356
P1433
P1476
Hypoxic regulation of glucose ...... s for anticancer therapeutics.
@en
P2093
Rachel E Airley
P2860
P304
P356
10.1159/000104457
P577
2007-06-25T00:00:00Z